Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany

Siegfried Kaspera Center for Brain Research, Medical University of Vienna, Austria

Annalisa Bonellib Angelini Pharma S.p.A, Rome, Italy

Agnese Cattaneob Angelini Pharma S.p.A, Rome, Italy

Alessandro Comandinib Angelini Pharma S.p.A, Rome, Italy

Giorgio Di Datob Angelini Pharma S.p.A, Rome, Italy

Franca Heimanc IQVIA Solutions Italy S.r.l., RWS, Milan, Italy

Valeria Pegoraroc IQVIA Solutions Italy S.r.l., RWS, Milan, ItalyCorrespondence[email protected]

Diego Palaod Department of Mental Health, Parc Taulí-University Hospital of Sabadell, Department of Psychiatry and Forensic Medicine, Unitat de Neurociència Traslacional I3PT-INc Autonomous University of Barcelona, Barcelona, Spain;e Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain

https://orcid.org/0000-0002-3323-6568

Miquel Rocaf Department of Medicine, IUNICS/IDISBA, University of Balearic Islands, Palma, Spain

Hans-Peter Volzg Hospital for Psychiatry, Psychotherapy and Psychosomatic Medicine, Werneck, Germany

show all

Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date